Cash Flow Statement

Amortization of Deferred Charges Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Accured Expenses Change in Cash Change in Receivables Depreciation & Amortization (CF)Free Cash Flow Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Income Share-based Compensation Shares Issued

Daily Values

Others

Inhibrx Biosciences (INBX) Long-Term Debt Issuances (2025)

Historic Long-Term Debt Issuances for Inhibrx Biosciences (INBX) over the last 1 years, with Q1 2025 value amounting to $100.0 million.